Banner image
Verdant Bioscience

Verdant Bioscience develops oil palm F1 hybrid varieties and other supporting technologies that underpin significant yield increases and productivity enhancements.

Included in the AvH investment portfolio since 2020.

42 %

Beneficial interest AvH
verdant

Key figures


$ 4.6 m

Turnover (2025)

$ -4.2 m

Net result (2025)

436

Employees (2025)

Press releases from the segment

View All
Energy & Resources

SIPEF delivers record results in 2025

Energy & Resources

SIPEF Interim Statement 9m2025: Heading for a Record Performance in 2025